NYSEHealth CareHealth Care FacilitiesS&P MidCap 400
$283.33
-3.13 (-1.09%)
Close of Nov 06, 2026 · end-of-day data
THC 8-K filings in 2026
Every material Form 8-K Tenet Health filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Tenet Healthcare reported third quarter 2026 net income available to common shareholders of $1.000 billion, or $12.41 per diluted share, up from $342 million, or $3.86, a year earlier, and raised its full-year 2026 Adjusted EBITDA outlook to $5.05 billion to $5.20 billion. The quarter includes a $147 million favorable net impact from timing-related adjustments tied to the early conclusion of revenue cycle management agreements with CommonSpirit Health, which the company says do not change its full-year revenue expectations.
Third quarter 2026 net income available to common shareholders was $1.000 billion, or $12.41 per diluted share, versus $342 million, or $3.86, in third quarter 2025.
Consolidated Adjusted EBITDA rose 23.3% to $1.355 billion, and adjusted diluted EPS increased 79.5% to $6.64.
FY 2026 Adjusted EBITDA outlook is now $5.05 billion to $5.20 billion, a $195 million increase at the midpoint of the range.
Third quarter results include a $147 million favorable net impact from transition activities and timing-related adjustments under the CommonSpirit agreements.
Tenet Healthcare issued $2 billion of 6.250% senior notes due 2034 on September 22, 2026. The company plans to use the net proceeds, with cash on hand, to redeem its $1.5 billion of 5.125% secured notes due 2027 and partly redeem $0.5 billion of its 6.125% notes due 2028. The deal refinances existing debt, and the filing does not state a change in total debt outstanding.
Issued $2,000,000,000 of 6.250% senior notes due 2034 on September 22, 2026
Proceeds, with cash on hand, to fund redemption of all $1.5 billion of 5.125% senior secured first lien notes due November 2027
Partial redemption of $0.5 billion of 6.125% senior notes due October 2028
Notes are redeemable at a make-whole premium before September 15, 2029, and at set redemption prices after that date
Tenet Healthcare reported second-quarter 2026 results on July 23, 2026, with net operating revenues of $5.628 billion, up 6.8% from a year earlier, and net income to common shareholders of $826 million, or $9.84 per diluted share, versus $288 million, or $3.14, in the second quarter of 2025. The company raised its full-year 2026 adjusted EBITDA outlook and authorized a $2.0 billion increase to its share repurchase program, which matters to shareholders because it lifts expected earnings and returns capital.
Adjusted diluted EPS rose 52.2% to $6.12 from $4.02 a year earlier.
Net income includes $413 million of revenue from the early termination of the CommonSpirit contract, which is excluded from net operating revenues.
FY 2026 adjusted EBITDA outlook is now $4.83 billion to $5.03 billion, a $295 million increase at the midpoint; adjusted free cash flow outlook is $2.725 billion to $3.025 billion.
The Board authorized a $2.0 billion increase to the share repurchase program, leaving $2.13 billion available as of July 23, 2026.
Tenet Healthcare reported first quarter 2026 net income available to common shareholders of $702 million, or $8.01 per diluted share, up from $406 million, or $4.27, a year earlier. Results include $413 million of revenue from the early conclusion of a contract with CommonSpirit Health, while adjusted EBITDA was roughly flat at $1.162 billion, and the company kept its full-year 2026 adjusted EBITDA outlook of $4.485 billion to $4.785 billion unchanged.
Net operating revenues rose 2.8% to $5,368 million from $5,223 million a year earlier.
Adjusted diluted EPS rose 10.6% to $4.82 from $4.36; GAAP diluted EPS was $8.01 versus $4.27.
Adjusted EBITDA was $1.162 billion versus $1.163 billion, and the full-year 2026 adjusted EBITDA outlook was kept at $4.485 billion to $4.785 billion.
The company repurchased 1.35 million shares for $318 million in the quarter.
Tenet Healthcare said Executive Vice President and Chief Information Officer Paola Arbour will retire effective December 31, 2026, under an agreement dated April 9, 2026. She will stay on in a non-executive, part-time role through April 1, 2028 to provide transition services, and the filing describes this as a routine officer transition with no stated effect on the company's results.
Retirement as Executive Vice President and Chief Information Officer effective December 31, 2026
Part-time non-executive employment through April 1, 2028, paid a weekly salary of $820
Eligible for a 2026 bonus under the Annual Incentive Plan but not for 2027
Outstanding equity awards continue to vest under their existing terms
Tenet Healthcare appointed J. Michael Grooms, currently Senior Vice President and Chief Accounting Officer at Lifepoint Health, as Senior Vice President and Controller effective April 6, 2026, and as Principal Accounting Officer effective May 1, 2026. The change replaces R. Scott Ramsey, whose retirement date was moved from March 31 to April 30, 2026; he will stay on part-time through March 31, 2028 for transition support.
J. Michael Grooms, age 48, joins as Senior Vice President and Controller effective April 6, 2026
Grooms succeeds R. Scott Ramsey as Principal Accounting Officer effective May 1, 2026
Grooms's offer includes a $475,000 base salary, a 60% target cash bonus, a $250,000 cash sign-on bonus and a $500,000 initial RSU grant
Ramsey's retirement is now effective April 30, 2026, and he remains employed part-time through March 31, 2028
Tenet Healthcare reported fourth-quarter 2025 net income available to common shareholders of $371 million, or $4.22 per diluted share, up from $318 million, or $3.32, a year earlier. It also gave a full-year 2026 outlook, with Adjusted EBITDA expected between $4.485 billion and $4.785 billion, and disclosed a CommonSpirit agreement involving $1.9 billion in payments tied to Conifer Health Solutions.
Q4 2025 net operating revenues were $5.527 billion, up 8.9% from $5.073 billion in Q4 2024.
Q4 2025 adjusted diluted EPS rose 36.6% to $4.70 from $3.44; Adjusted EBITDA rose 12.9% to $1.183 billion.
Full-year 2025 net income available to common shareholders was $1.407 billion, or $15.49 per diluted share, versus $3.2 billion in 2024, which included a $2.916 billion pre-tax gain on hospital divestitures.
FY 2026 outlook: net operating revenues of $21.5 billion to $22.3 billion and Adjusted EBITDA of $4.485 billion to $4.785 billion.
Tenet Healthcare said its 2025 Adjusted EBITDA is expected to come in at the upper end of its $4.47 billion to $4.57 billion guidance range, based on preliminary figures that are not yet final. The company also completed a transaction with CommonSpirit Health that ends CommonSpirit's 23.8% stake in Conifer Health Solutions and gives Tenet about $1.9 billion in payments over three years, which Tenet says reduces its balance sheet liabilities by about $885 million.
Expected 2025 Adjusted EBITDA is at the upper end of the $4.47 billion to $4.57 billion guidance range; final results are due February 11, 2026
CommonSpirit to pay Tenet about $1.9 billion in annual installments over the next three years
Conifer redeems CommonSpirit's 23.8% equity stake for $540 million, effective January 1, 2026
Revenue cycle services for CommonSpirit end at the close of 2026; balance sheet liabilities fall about $885 million and paid-in capital rises about $305 million
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Tenet Health filing is on SEC EDGAR ↗. 8-K briefs of other companies →